Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA--(BUSINESS WIRE)—OptraSCAN, Inc....

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended...

Immunohistochemistry (IHC) stained tissue sections are read and interpreted by a pathologist using a microscope, or on a computer monitor as routine use of digital pathology continues to grow. Regardless of interpretation method, It is well...